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Acute knockdown of the insulin 
receptor or its substrates Irs1 and 
2 in 3T3-L1 adipocytes suppresses 
adiponectin production
Matthijs P. Groeneveld1,2,*, Gemma V. Brierley1,2,*, Nuno M. Rocha1,2, Kenneth Siddle1,2 & 
Robert K. Semple1,2
Loss of function of the insulin receptor (INSR) in humans produces severe insulin resistance. Unlike 
“common” insulin resistance, this is associated with elevated plasma levels of the insulin-sensitising, 
adipose-derived protein adiponectin. The underlying mechanism for this paradox is unclear, and it is 
at odds with the acute stimulation of adiponectin secretion reported on insulin treatment of cultured 
adipocytes. Given recent evidence for ligand-independent actions of the INSR, we used a lentiviral 
system to knock down Insr or its substrates Irs1 and Irs2 conditionally in 3T3-L1 murine preadipocytes/
adipocytes to assess whether acute loss of their expression has different consequences to withdrawal 
of insulin. Efficient knockdown of either Insr or Irs1/2 was achieved by conditional shRNA expression, 
severely attenuating insulin-stimulated AKT phosphorylation and glucose uptake. Dual knockdown 
of Irs1 and Irs2 but not Insr in preadipocytes impaired differentiation to adipocytes. Acute knockdown 
of Insr or both Irs1 and Irs2 in adipocytes increased Adipoq mRNA expression but reduced adiponectin 
secretion, assessed by immunoassay. Knockdown sustained for 14 days also reduced immunoassay-
detected adiponectin secretion, and moreover induced delipidation of the cells. These findings argue 
against a distinct effect of Insr deficiency to promote adiponectin secretion as the explanation for 
paradoxical insulin receptoropathy-related hyperadiponectinaemia.
Insulin drives macronutrient storage and tissue growth by inducing trans-autophosphorylation of its receptor, 
which is a dimeric transmembrane receptor tyrosine kinase (RTK). This results in phosphorylation of insulin 
receptor substrates (IRSs) 1 and 2 and activation of a widely ramifying signalling network including, but not 
limited to, the phosphatidylinositol-3-kinase/AKT/mTOR and RAS/MEK/ERK pathways1.
Insulin resistance is commonly associated with type 2 diabetes mellitus, fatty liver, dyslipidaemia and ovu-
latory dysfunction2. However loss of insulin receptor (INSR) function produces a distinctive insulin resistance 
subphenotype, with severely impaired responsiveness of blood glucose levels to insulin and subfertility but nei-
ther fatty liver disease nor dyslipidaemia3. Moreover, while plasma levels of the abundant adipose-derived protein 
adiponectin are lowered in prevalent insulin resistance4 they are preserved or increased, sometimes extremely, in 
INSR dysfunction5,6. Hyperadiponectinaemia in mice with adipose- specific Insr knockout7 implicates increased 
adiponectin production rather than reduced clearance in this. Insulin stimulates adiponectin secretion from cul-
tured adipocytes (e.g8), however, at odds with the in vivo observations. These findings could be reconciled if the 
INSR has ligand-independent functions relevant to adiponectin production. Evidence for ligand-independent 
INSR functions has recently emerged with the finding that its knockout confers resistance to apoptosis upon 
murine brown preadipocytes if Igf1r is concomitantly deleted9.
INSR is commonly co-expressed with IGF1R, which activates a nearly identical signalling pathway, yet their 
biological effects are distinct. This is likely to be accounted for in part by tissue expression profiles of the recep-
tors1. The role of adipocyte IGF1R homodimer is minor or negligible compared to that of the INSR10 and so in 
adipocytes ligand-independent effects of the INSR may be physiologically relevant. To assess whether loss of non 
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ligand-dependent actions of the INSR accounts for the hyperadiponectinaemia of insulin receptoropathy, we 
conditionally knocked down Insr or Irs1 and Irs2 (Irs1/2) in murine 3T3-L1 adipocytes.
Results and Discussion
3T3-L1 preadipocyte lines were generated allowing knockdown of Insr or Irs1/2 by doxycycline-dependent 
expression of shRNA. Clonal cell lines were screened for knockdown efficiency, and subsequent studies under-
taken using the most efficient lines. After differentiation to adipocytes highly efficient knockdown of Insr or 
Irs1/2 mRNA and protein was induced by 72 hours of doxycycline treatment (Fig. 1A,B). Knockdown after differ-
entiation did not affect cellular lipid content (Fig. 1I) but severely attenuated insulin-induced Akt phosphoryla-
tion (Fig. 1C) and 2-deoxyglucose uptake (Fig. 1D). Insulin-dependent glucose uptake depends upon Akt, and 
half maximal uptake requires an Akt phosphorylation level of only 5–22% of its maximum11. Thus severe blunting 
of this response confirms potent Insr and Irs1/2 knockdown.
One challenge when using shRNA to study gene function in adipocytes is that some genes of interest are also 
involved in preadipocyte differentiation, and their stable knockdown precludes efficient adipocyte generation. 
Early studies using genetically engineered 3T3 cells suggested that Insr function is required for adipogenesis, 
although prolonged passage of cells may have reduced the differentiative capacity of the cells12. Recent studies 
using cre-mediated gene deletion in murine primary brown preadipocytes have instead suggested that Insr and 
Igf1r play redundant roles in early adipogenesis, and that the Insr is thus dispensable for the process13.
Our cellular model of inducible Insr knockdown enabled us to re-address this question in 3T3-L1 cells. In 
keeping with previous reports (e.g.14) Insr expression was up-regulated during differentiation (Fig. 1E), while 
Igf1r expression decreased (Fig. 1E). Moreover, expression of Igf1r was not detectable after fractionation of 
lipid-rich cells to remove residual undifferentiated cells (Fig. 1F). On doxycycline treatment of preadipocytes Insr 
protein was reduced after 12 hours, near complete knockdown being achieved at 72 hours (Fig. 1G). Knockdown 
induced between day − 3 and day 6 of differentiation only modestly impaired triglyceride accumulation (Fig. 1H), 
while Irs1/2 knockdown impaired lipidation more severely (Fig. 1H). Insr knockdown for 14 days after adipocyte 
differentiation led to striking delipidation of the cells (Fig. 1J).
These findings suggest that in the 3T3-L1 adipocyte cell line, as in murine brown primary preadipocytes9, 
Insr plays a predominant role only in the later phase of adipogenesis, when it is highly expressed relative to Igf1r. 
Indeed, although Insr knockout mice die before day 3 of postnatal life with reduced fat cell mass, adipocytes are 
detectable, indicating that the role of the Insr in adipogenesis in vivo, too, is not obligate12. The more deleterious 
effect of Irs1/2 knockdown is consistent with previous findings15, and may be accounted for by their involvement 
in both Insulin and IGF1 signalling.
Our study was primarily motivated by the unexplained discordance in patients with loss of Insr function 
between elevated adiponectin and severe insulin resistance5,6. We thus sought to use our model of conditional 
Insr deficiency to test whether non ligand-dependent actions of the Insr may be important for regulation of 
adiponectin secretion. After inducing knockdown in differentiated 3T3-L1 adipocytes, secreted adiponec-
tin was measured over 24 hours using a DELFIA assay and immunoblotting. Both Insr and Irs1/2 knockdown 
reduced adiponectin secretion assessed by immunoassay (Fig. 2A), although the effect was not apparent in 
non-denaturing, non-reducing immunoblots, where the complex higher order structure of adiponectin renders 
interpretation more complex (Fig. 2B). AdipoQ mRNA, encoding adiponectin, was increased in adipocytes by 
Insr knockdown, however the difference between Irs1/2 knockdown cells and doxycycline-free controls was not 
significant (Fig. 2C).
Some previous data suggest that the acute increase in adiponectin secretion seen on insulin treatment is tran-
sient and induced by altered endoplasmic reticulum redox tone8. It thus remains possible that increased AdipoQ 
mRNA is more relevant to the in vivo setting, in keeping with reports that in humans low plasma adiponectin 
corresponds to low adipose ADIPOQ mRNA16,17. Knockdown of either Insr or Irs1/2 for 2 weeks in adipocytes 
once again decreased adiponectin secretion as assessed by immunoassay (Fig. 2D), with no difference discerned 
by immunoblotting (Fig. 2E). AdipoQ mRNA expression showed no significant response to Insr knockdown, but 
was modestly increased by Irs1/2 knockdown (Fig. 2F). These findings argue against the hypothesis that insulin 
has divergent acute and long-term effects on adiponectin secretion.
Our findings do not support the notion that the hyperadiponectinaemia of insulin receptoropathy is explained 
by consequences of INSR deficiency on adipocyte-autonomous adiponectin expression or secretion, however are 
in keeping with a preponderance of prior studies assessing the consequences of insulin stimulation of adipocytes. 
The human biochemical paradox thus remains unexplained. Culture conditions used may not adequately mimic 
the in vivo cellular milieu, or the adipocytes studied may not represent the adipose depot driving the in vivo 
phenomenon22. Alternatively, loss of INSR function may affect adiponectin levels indirectly through alteration 
of adipocyte turnover. Further insights may require study of different adipose depots from patients with loss of 
INSR function.
Methods
Lentivirus production and Infection. 4–6 murine miR-shRNAs from Open Biosystems were 
screened per target and the most potent miR-shRNAs identified were cloned into either pSLIK-NEO or 
pTRIPZ-PURO (Open Biosystems) lentiviral expression vectors, as previously described18, and targeted the 
sequences: CTGGGACTGGAGCAAACACAA (Insr), GGATCCCATATCAGTTTCTAA (Insr), TTGGGTG- 
GAGAGAGTATTAAA (Irs1) and ACTCGGACAGCTTCTTCTTCA (Irs2). Virus was packaged by transfecting 
the lentivector expression vectors along with third-generation lentivirus packaging and pseudotyping plasmids 
(pMDLg/pRRE, pRSVREV and pVSV-G) into HEK293T cells using the calcium phosphate transfection method 
(Clontech). 3T3-L1 preadipocytes were infected with pTRIPZ virus at low MOI to ensure that most transduced 
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cells contained single integrants. After puromycin selection cells were infected with pSLIK, also at low MOI, and 
selected with both G418 and puromycin.
Cell culture. 3T3-L1 preadipocyte maintainance and differentiation were performed as previously 
described19. Experiments were undertaken at day 7 of differentiation unless otherwise indicated.
Figure 1. Conditional knockdown of Insr or Irs1/Irs2 in 3T3-L1 adipocytes. 3T3-L1 adipocytes harbouring 
DOX-inducible miR-shRNAs targeting the Insr (INSR KD) or Irs1 and 2 (IRS1/2 KD) were exposed to DOX 
for 72 hours from day 7 of differentiation. (A) Insr mRNA and protein levels in INSR KD cells compared to 
controls (B) Irs1 and Irs2 mRNA and protein levels in IRS1/2 KD cells. (C) AKT Ser473 phosphorylation after 
serum starvation and exposure to 10nmol/l insulin for 5 minutes. (D) 2-deoxyglucose uptake after exposure to 
50nmol/l insulin. (E) Western blot analysis of Insr and Igf1r expression in differentiating wild-type (WT) 3T3-
L1 pre-adipocytes. Days post initiation of differentiation are shown. (F) Expression of Igf1r and aP2 in isolated, 
lipid-laden WT 3T3-L1 adipocytes after 6 days of differentiation. (G) Time-course of Insr protein expression 
in differentiated 3T3-L1 cells in response to DOX. (H) Oil-Red-O staining of WT, INSR and IRS1/2 KD cells 
differentiated for 8 days. DOX was added at the timepoints indicated in the schematic. (I) Oil-Red-O staining 
of 3T3-L1 WT, INSR KD and IRS1/2 KD cells ± doxycycline for 72 hours. Images are representative of 3 
independent experiments. (J) Oil-Red-O staining of 3T3-L1 WT, INSR KD and IRS1/2 KD cells ± doxycycline 
for 14 days from day 7 of differentiation. Images are representative of 3 independent experiments. Error bars 
represent mean ± S.E.M. from 3 independent experiments. Paired two-tailed Student’s  
t test; *denotes p < 0.05, ***p < 0.001 and non-significant (n.s.) indicates p > 0.05.
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Lipid droplet accumulation. Lipid droplet accumulation in mature adipocytes was visualized by Oil-red-O 
staining as previously described15.
Insulin stimulation studies and glucose uptake assays. For insulin stimulation studies, cells were 
washed twice with warm PBS and serum starved in serum-free DMEM medium containing 0.5% bovine serum 
albumin 16 hours before insulin stimulation. Deoxyglucose uptake was assessed on day 10 of differentiation in 
12-well plates essentially as previously described20.
Measurement of secreted adiponectin. For determination of secreted adiponectin, confluent adipocyte 
cultures were washed with warm PBS before adding 2.0 ml DMEM containing 10% (v/v) FBS. Medium was col-
lected after 24 hours and used for auto-dissociation-enhanced lanthanide fluorescence immunoassay (DELFIA) 
of adiponectin as described previously21.
Western blot. Cells were washed with cold PBS, snap frozen in liquid nitrogen, thawed and scraped in mod-
ified RIPA buffer (substitution of 1% (v/v) Triton-X 100 instead of SDS) containing Complete Mini protease 
inhibitor cocktail (Roche). Protein concentrations were determined with the Bradford protein assay (Bio-Rad). 
Where indicated, mature adipocytes were isolated from undifferentiated cells employed trypsinisation of cells 
after differentiation before suspension in 25ml DMEM and centrifugation at 360 ×g for 9 minutes. Floating adi-
pocytes were transferred to a new tube and centrifuged at 4,255 ×g for 7 minutes before lysing of the pellet. 
After SDS–polyacrylamide gel electrophoresis and transfer to a polyvinylidene difluoride membrane using the 
iBlot dry blotting system (Invitrogen) and immunoblotted with the appropriate antibodies, proteins were visu-
alized using enhanced chemoluminescence (GE Healthcare or Millipore). When necessary blots were stripped 
and reblotted using “Re-blot Plus” (Millipore). Antibodies (with catalogue number) used for Western blot were: 
INSR (sc-711), IGF1R (sc-713) were purchased from Santa Cruz Biotechnologies. Phospho-Ser473-AKT (9271), 
IRS1 (2382) and IRS2 (3089) were purchased from Cell Signalling. Adiponectin (MAB3608) was purchased from 
Milipore. Calnexin (ab75801), GAPDH (ab8245), AP2 (ab66682) and secondary antibodies: horseradish perox-
idase (HRP)–conjugated anti-rabbit and anti-mouse immunoglobulin G (IgG) were purchased from (Abcam).
Figure 2. Effect on adipocyte adiponectin synthesis and secretion of Insr or Irs1/Irs2 knockdown. 3T3-L1 
preadipocytes were differentiated for 7 days prior to induction of shRNA expression using DOX for 72 hours 
(A–C) or 14 days (D–F). (A) Adiponectin concentrations determined by DELFIA assay in medium conditioned 
for 24 hours. (B) Adiponectin in 24 hour conditioned medium determined by non-denaturing, non-reducing 
polyacrylamide gel electrophoresis and immunoblotting. (C) Cellular AdipoQ expression determined by 
quantitative real time PCR mRNA levels and normalised to expression of Rplp0. (D–F) show the same analyses 
after 14 days of exposure to DOX. Western blots are representative of five independent experiments. Error 
bars represent mean ± standard error of the mean from at least 3 independent experiments. Paired two-tailed 
Student’s t test was used to test significance; *p < 0.05; **p < 0.01; n.s. (non-significant) indicates p > 0.05.
www.nature.com/scientificreports/
5Scientific RepoRts | 6:21105 | DOI: 10.1038/srep21105
RNA isolation and Real-time PCR analysis. Total RNA was extracted using an RNeasy mini kit 
including on-column DNAseI digestion (Qiagen). RNA was reverse- transcribed using M-MLV Reverse 
Transcriptase (Promega) according to the manufacturer’s instructions. Taqman real time PCR was performed 
starting with 10 ng of cDNA, sense and antisense oligonucleotides (333 nM) and a 5′-[6FAM], 3′-[TAMRA]- 
labeled fluorogenic probe (167 nM) (Sigma-Aldrich) using PCR Taqman Mastermix (Applied Biosystems) in 
a final volume of 12 μ l. Fluorescence was monitored and analysed in an ABI Prism 7900 HT sequence detec-
tion system (Applied Biosystems). Quantification utilised the relative standard curve method with expres-
sion of the gene of interest normalized to that of the reference gene Rplp0. Primer and probe sequences (5′ 
- 3′) were as follows: (Insr sense primer) CAATGGGACCACTGTATGCATTCT, (Insr antisense primer) 
GTCCGGCACGTACACGAAGA, (Insr probe) TGAGTACCTCAGTGCCAGTGATGTGTTTCC, (AdipoQ 
sense primer) CAGTGGATCTGACGACACCAA, (AdipoQ antisense primer) TGGGCAGGATTAAGAG- 
GAACA, (AdipoQ  probe) GGGCTCAGGATGCTACTGT TGCAAGC, (RPLP0 sense primer) 
GGACCCGAGAAGACCTCCTT, (Rplp0 antisense primer) TCAATGGTGCCTCTGGAGATT, (Rplp0 probe) 
CCAGGCTTTGGGCATCACCACG, (Irs1 Taqman assay, Applied Biosystems) Mm01278327-m1, (Irs2 Taqman 
assay, Applied Biosystems) Mm03038438-m1.
Statistical Analysis. Data are presented as mean ± standard error of the mean (SEM) from three independ-
ent experiments. Paired two-tailed Student’s t-test were used to determine statistical significance and were calcu-
lated using GraphPad Prism.
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